Here we show that similar to conditioning CD8+ T cells to low oxygen tensions before ACT, a transient boost in HIF signalling through ex vivo treatment with the PHD inhibitor FG-4592 improved the expansion and cytotoxicity of adoptively transferred tumour-specific mouse and human CD8+ T cells. Here, CD8A is linked to neoplasm.